The 3rd webinar in the series of MACRAMÉ Webinars on Harmonisation, Standardisation & Validation of Test- and Characterisation Methods focussed on the topic Overcoming issues in regulatory testing of advanced materials. …
The webinar will inform you about different standardisation organisations (e.g. ISO, CEN, OECD) and the process towards an accepted standard. This includes the important steps of method validation and regulatory acceptance. An overview of the state-of-the-art of human health and environmental in vitro testing of the advanced materials will be given. …
MEDICA S.p.A. is a prominent firm specializing in electromedical devices and single-use medical products, boasting more than 50 patents and a dedicated emphasis on innovation and research. Utilizing capillary membrane spinning technology for blood and water purification sets this company apart as the sole Italian entity, showcasing its continuous commitment to technological progress. …
The MACRAMÉ Project was invited to give evidence to the 5th Stakeholder Workshop on ‘Safe & Sustainable by Design’, hosted by the European Commission on the 5. and 6. December 2024 in Brussels. Based on the feedback that the MACRAMÉ Project had provided during the second testing period, the Project Read more
Colleagues from the MACRAMÉ Partner University Birmingham contributed to a new review paper. The study conducts an exhaustive analysis of the state-of-the-art developments in the creation and enhancement of MXene-based membranes. Membranes have become a basis in tackling the global challenge of freshwater scarcity, notably in the fields of desalination and water purification.
The European Green Deal sets a roadmap for a sustainable future by 2050, aiming for a toxic-free environment and a circular economy. Key strategies include the Zero Pollution Ambition, the Circular Economy Action Plan, and the Chemicals Strategy for Sustainability. Central to these efforts is the Safe and Sustainable by Read more
At BASF, we create chemistry for a sustainable future by combining economic success with environmental protection and social responsibility. With around 112,000 employees contributing to the group’s success globally, we are one of the world’s largest chemical companies, present in …
MACRAMÉ Partner EMPA published a paper with the title ‘Bridging the gap: Innovative human-based in vitro approaches for nanomaterials hazard assessment and their role in safe and sustainable by design, risk assessment, and life cycle assessment’. The application of nanomaterials in industry and consumer products is growing exponentially, which has pressed the development and use of predictive human in vitro models in pre-clinical analysis to closely extrapolate potential toxic effects in vivo.
GAIKER is a private non-profit organisation devoted to research and the provision of innovative technological solutions to companies. Since we were set up in 1985, we have contributed to the technological development and competitiveness of the business sector through learning, development and …
MACRAMÉ Coordinator, Dr Steffi Friedrichs, presented the project’s interim results at the NanoTox 2024 conference, held 23. to 25. September in Venice (Italy). In a presentation entitled ‘Interim Results of the MACRAMÉ R&I Approach – Ensuring regulatory Alignment in the Research & Innovation of five market-relevant Advanced Materials’, Dr Friedrichs Read more
